Singapore shall not require product filing or approval for insurance products other than for life insurance products [Life insurance products here would include non-short term accident and health policies and term policies exceeding five years.], Central Provident Fund-related products and investment-linked products. Where product filing or approval is required, Singapore shall allow the introduction of the product, which Singapore shall deem to be approved unless the product is disapproved within a reasonable time, endeavouring to do so in 30 days. Singapore shall not maintain limitations on the number or frequency of product introduction. This specific commitment does not apply where a financial institution of the Union seeks to supply a new financial service pursuant to Article 8.53 (New Financial Services).
, Free trade Agreement between the European Union and the Republic of Singapore
In forcesince 17 Apr 2020